Sebastian Palmqvist

Overview

Best Publications

• Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders.

  Sebastian Palmqvist;Shorena Janelidze;Yakeel T. Quiroz;Yakeel T. Quiroz;Henrik Zetterberg

  1399
  Citations

• Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.

  Thomas K. Karikari;Tharick A. Pascoal;Tharick A. Pascoal;Nicholas J. Ashton;Shorena Janelidze

  1260
  Citations

• Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia

  Shorena Janelidze;Niklas Mattsson;Sebastian Palmqvist;Ruben Smith

  1159
  Citations

• Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity

  Sebastian Palmqvist;Michael Schöll;Michael Schöll;Olof Strandberg;Niklas Mattsson

  901
  Citations

• Plasma β-amyloid in Alzheimer’s disease and vascular disease

  Shorena Janelidze;Erik Stomrud;Sebastian Palmqvist;Henrik Zetterberg;Henrik Zetterberg

  634
  Citations

• Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline

  Unknown

  536
  Citations

• Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer's disease.

  Joana B Pereira;Joana B Pereira;Shorena Janelidze;Ruben Smith;Niklas Mattsson-Carlgren

  533
  Citations

• Spread of pathological tau proteins through communicating neurons in human Alzheimer's disease

  Jacob W. Vogel;Yasser Iturria-Medina;Olof T. Strandberg;Ruben Smith

  522
  Citations

• A multicentre validation study of the diagnostic value of plasma neurofilament light.

  Nicholas J. Ashton;Shorena Janelidze;Ahmad Al Khleifat;Antoine Leuzy

  512
  Citations

• Plasma tau in Alzheimer disease

  Niklas Mattsson;Henrik Zetterberg;Henrik Zetterberg;Henrik Zetterberg;Shorena Janelidze;Philip S. Insel

  505
  Citations

• Prediction of future Alzheimer's disease dementia using plasma phospho-tau combined with other accessible measures.

  Sebastian Palmqvist;Pontus Tideman;Nicholas Cullen;Henrik Zetterberg

  503
  Citations

• CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease

  Shorena Janelidze;Henrik Zetterberg;Niklas Mattsson;Sebastian Palmqvist

  483
  Citations

• Discriminative accuracy of [18F]flortaucipir positron emission tomography for Alzheimer disease vs other neurodegenerative disorders

  Rik Ossenkoppele;Rik Ossenkoppele;Gil D. Rabinovici;Ruben Smith;Hanna Cho

  468
  Citations

• Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease-Related β-Amyloid Status.

  Sebastian Palmqvist;Shorena Janelidze;Erik Stomrud;Henrik Zetterberg

  435
  Citations

• Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer's disease.

  Shorena Janelidze;Erik Stomrud;Ruben Smith;Sebastian Palmqvist

  427
  Citations

• Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease

  Sebastian Palmqvist;Henrik Zetterberg;Niklas Mattsson;Per Johansson

  405
  Citations

• Accuracy of Brain Amyloid Detection in Clinical Practice Using Cerebrospinal Fluid β-Amyloid 42: A Cross-Validation Study Against Amyloid Positron Emission Tomography.

  Sebastian Palmqvist;Henrik Zetterberg;Kaj Blennow;Susanna Vestberg

  403
  Citations

• Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography.

  Sebastian Palmqvist;Niklas Mattsson;Oskar Hansson

  393
  Citations

• Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease

  Sebastian Palmqvist;Philip S Insel;Philip S Insel;Erik Stomrud;Shorena Janelidze

  378
  Citations

• CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease.

  Shorena Janelidze;Niklas Mattsson;Erik Stomrud;Olof Lindberg

  357
  Citations

• Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease.

  Niklas Mattsson;Philip S Insel;Philip S Insel;Sebastian Palmqvist;Erik Portelius

  307
  Citations